Theravance Biopharma, Inc. Reports Third Quarter 2015 Financial Results and Provides Business Update

Go back to Theravance Biopharma, Inc. Reports Third Quarter 2015 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Tops Q3 EPS by 4c

November 9, 2015 5:06 PM EST

Theravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($1.40), $0.04 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More